DS
OSIR

David Shaw’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

David Shaw’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-140,978
Closed -$692K – 3820
2016
Q4 		$692K Buy
140,978
+32,808
+30% +$168K ﹤0.01% 2678
2016
Q3 		$537K Sell
108,170
-3,388
-3% -$17.3K ﹤0.01% 2760
2016
Q2 		$568K Buy
111,558
+14,937
+15% +$80.4K ﹤0.01% 2740
2016
Q1 		$552K Buy
96,621
+77,465
+404% +$541K ﹤0.01% 2737
2015
Q4 		$199K Sell
19,156
-50,339
-72% -$683K ﹤0.01% 3563
2015
Q3 		$1.28M Sell
69,495
-54,608
-44% -$1.05M ﹤0.01% 2425
2015
Q2 		$2.42M Buy
124,103
+57,499
+86% +$1.02M ﹤0.01% 2042
2015
Q1 		$1.17M Buy
66,604
+52,818
+383% +$887K ﹤0.01% 2443
2014
Q4 		$220K Buy
+13,786
New +$185K ﹤0.01% 3774
2014
Q3 		– Sell
-10,653
Closed -$166K – 4706
2014
Q2 		$166K Buy
+10,653
New +$157K ﹤0.01% 4028
2014
Q1 		– Sell
-10,418
Closed -$168K – 4991
2013
Q4 		$168K Sell
10,418
-9,448
-48% -$151K ﹤0.01% 4306
2013
Q3 		$331K Buy
19,866
+657
+3% +$9.71K ﹤0.01% 3853
2013
Q2 		$193K Buy
+19,209
New +$202K ﹤0.01% 3769

Other funds holding OSIR

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

David Shaw's OSIR Position: Q1 2017 in Review

David Shaw sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 140,978 shares — an estimated $692K sold.

David Shaw first reported a position in OSIR in Q2 2013 and held it in 13 quarters. The position peaked at $2.42M in Q2 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

  • David Shaw reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • David Shaw sold 140,978 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $692K.
  • David Shaw first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
  • David Shaw's Osiris Therapeutics, Inc. Common Stock position peaked at $2.42M in Q2 2015.
  • 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.